Next Article in Journal
Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab
Previous Article in Journal
EVs as Potential New Therapeutic Tool/Target in Gastrointestinal Cancer and HCC
Open AccessArticle

Article Versions Notes

Cancers 2020, 12(10), 3020; https://doi.org/10.3390/cancers12103020
Action Date Notes Link
article pdf uploaded. 17 October 2020 13:40 CEST Updated version of record https://www.mdpi.com/2072-6694/12/10/3020/pdf
article supplementary file uploaded. 17 October 2020 13:40 CEST - https://www.mdpi.com/2072-6694/12/10/3020#supplementary
article xml file uploaded 20 October 2020 05:59 CEST Update https://www.mdpi.com/2072-6694/12/10/3020/xml
article xml uploaded. 20 October 2020 05:59 CEST Update https://www.mdpi.com/2072-6694/12/10/3020/xml
article pdf uploaded. 20 October 2020 05:59 CEST Updated version of record https://www.mdpi.com/2072-6694/12/10/3020/pdf
article html file updated 20 October 2020 06:01 CEST Update https://www.mdpi.com/2072-6694/12/10/3020/html
Back to TopTop